Q301--Kidney Disease Gene Panel 1-Year Testing Indy, Cleveland, Cincinnati VA Medical Centers
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
250-NETWORK CONTRACT OFFICE 10 (36C250)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C25026Q0377
NAICS
621511 - Medical Laboratories
Classification Code
Q301
Additional Details
Documents1
This Sources Sought Notice, issued under procurement identifier 36C25026Q0377, seeks to identify qualified contractors capable of providing specialized kidney disease genetic testing services for the Veterans Health Administration (VHA), specifically supporting the Richard L. Roudebush VA Medical Center in Indianapolis, the Louis Stokes Cleveland VA Medical Center, and the Cincinnati VA Medical Center. The notice is released by the Network Contracting Office (NCO) 10, located in Ann Arbor, MI, as part of market research in accordance with FAR Part 10. It is important to note that this is not a solicitation; rather, it is an information-gathering effort to assess industry capabilities and inform future procurement planning.
The intended scope of the contract encompasses comprehensive reference laboratory testing services for chronic kidney disease (CKD) over a one-year base period. The contractor will be responsible for performing advanced genetic analyses, including kidney gene panel testing (analyzing over 380 genes via blood or saliva), kidney transplant assessment (non-invasive donor-derived cell-free DNA testing for organ rejection and tumor evaluation), and molecular residual disease (MRD) assays (personalized, tumor-informed ctDNA detection). Estimated annual test volumes are provided for each participating facility, with the highest demand at the Cincinnati VA Medical Center.
Key requirements include:
- Full compliance with all applicable federal, state, and VA regulations, including CLIA, CAP, The Joint Commission, OSHA, HIPAA, and NFPA 99.
- Maintenance of all necessary certifications and licenses, with the laboratory director required to be an American Board of Pathology certified pathologist.
- Provision of all supplies necessary for specimen collection, preparation, storage, packaging, and shipping, including temperature-controlled containers and compliant labeling for infectious materials.
- Paid transportation of specimens from VA facilities to the contractor’s laboratory, ensuring sample integrity throughout the process.
- Secure, timely electronic reporting of test results to each facility, with robust data privacy and alternate reporting methods in case of system failure.
- Accessible customer service support for VA staff, with designated points of contact for issue resolution.
- Adherence to VA and VHA policies, including those related to credentialing, health information management, and the special needs of the veteran patient population.
The applicable NAICS code for this requirement is 621511 (Medical Laboratories), with a size standard of $41.5 million. The Product Service Code is Q301 (Medical Reference Laboratory Testing). The primary place of performance is Indianapolis, IN, with services also required in Cleveland, OH, and Cincinnati, OH.
Contractors responding to this notice must provide detailed company information, including business size and type (e.g., SDVOSB, VOSB, 8(a), WOSB, etc.), DUNS and Tax ID numbers, and evidence of registration in the System for Award Management (SAM). SDVOSB and VOSB respondents must also provide current VetCert certification. If services are available via a Federal Supply Schedule, contractors should provide relevant contract numbers and SINs; otherwise, they must indicate which items are offered on an open market basis.
Responses are due by March 13, 2026, at 8:30 AM EDT and must be submitted via email to Jessica Bryant at [email protected], with the subject line referencing the notice number and firm name. All information provided is voluntary and will be used solely for market research purposes; no compensation will be provided for responses.
This opportunity is particularly suited for laboratories with demonstrated expertise in advanced genetic testing for kidney disease, robust compliance infrastructure, and the capacity to serve multiple VA medical centers with high standards of quality, security, and customer service. Contractors should carefully review the attached draft Performance Work Statement and test list for further details on technical and operational expectations.
For additional information and to access the official notice, interested parties may visit the SAM.gov opportunity at: https://sam.gov/opp/74ce82ba2ee54e219817d9bc689b93a1/view.